Showing 1081-1090 of 21420 results for "".
- AI Analysis Maps Environmental and Immune Signatures in Pediatric ADhttps://reachmd.com/news/ai-analysis-maps-environmental-and-immune-signatures-in-pediatric-atopic-dermatitis/2488367/A machine learning (ML)-based analysis of environmental, immune, and transcriptomic data identified distinct protective and susceptibility clusters associated with pediatric atopic dermatitis (AD) among AmaXhosa children in South Africa. Published in PLoS Medicine, the observation
- Digital Primary Care Tools Improve Patient Safety Measureshttps://reachmd.com/news/digital-primary-care-tools-improve-patient-safety-measures/2488314/Key Takeaways Across randomized trials of digital patient safety interventions in primary care, medication-related and non-medication safety process measures improved significantly. Adverse events were also reduced, but the signal was more modest than the gains seen
- Oseltamivir Linked to Lower ICU Risk in Hospitalized Childrenhttps://reachmd.com/news/oseltamivir-linked-to-lower-icu-risk-in-hospitalized-children/2488310/Key Takeaways In children hospitalized with laboratory-confirmed influenza in the FluSurv-NET cohort, oseltamivir use was associated with significantly lower ICU admission risk. The lower ICU association also remained significant wh
- Autonomous Oxygen Titration Improved Normoxemia in SAVE-O2 AIhttps://reachmd.com/news/autonomous-oxygen-titration-improved-normoxemia-in-save-o2-ai/2488324/Key Takeaways In acutely ill hospitalized adults receiving supplemental oxygen, autonomous titration produced more time in the SpO2 target range than manual titration. Time in hypoxemia was significantly lower with autonomous titration than with manual titration.
- Keratometry Agreement Falls Short for Toric IOL Planninghttps://reachmd.com/news/keratometry-agreement-falls-short-for-toric-iol-planning/2488319/Key Takeaways In routine cataract workup at a single center in Korea, population-level agreement in J0 and J45 was not significantly different across KR-800, IOLMaster 500, and Pentacam HR. Average agreement across devices did not translate into reliable interchangea
- Consensus Statement: JAK Inhibitors Emerge as Primary Therapy for Severe Alopeciahttps://reachmd.com/news/consensus-statement-jak-inhibitors-emerge-as-primary-therapy-for-severe-alopecia/2488332/A US expert consensus provides a standardized treatment framework for adults with severe alopecia areata (AA), placing oral Janus kinase (JAK) inhibitors at the center of long-term disease management.
- More Negative Sentinel Nodes Didn’t Improve Breast Cancer Outcomeshttps://reachmd.com/news/more-negative-sentinel-nodes-didnt-improve-breast-cancer-outcomes/2488299/Key Takeaways In a 1,551-patient single-center cohort of cT1-2N0M0 breast cancer with negative sentinel nodes, 5-year DFS and OS did not differ significantly across groups with 1-3, 4-6, or at least 7 nodes removed. Adjusted analyses did not identify sentinel-node co
- RHOB Signaling May Explain Nocturnal IOP Rise in Glaucomahttps://reachmd.com/news/rhob-signaling-may-explain-nocturnal-iop-rise-in-glaucoma/2488300/Key Takeaways In a preclinical Communications Biology study using human trabecular meshwork cells and mice, norepinephrine signaling was linked to nocturnal IOP elevation through RHOB in the eye's drainage pathway. Shared gene-expre
- Capnography Missed PaCO2 in Most Prehospital Intubationshttps://reachmd.com/news/capnography-paco2-prehospital-intubations/2488292/Key Takeaways In a single Southern Finland HEMS cohort of critically ill patients after prehospital emergency anesthesia and intubation, most had a PaCO2-EtCO2 gradient above the assumed threshold. Overall agreement between arterial and end-tidal carbon dioxide was w
- Upadacitinib Shows Sustained Responses in PsA After Prior TNF Inhibitor: Analysishttps://reachmd.com/news/upadacitinib-shows-sustained-responses-in-psa-after-prior-tnf-inhibitor-analysis/2488287/A post hoc analysis of SELECT-PsA 2 found sustained responses with upadacitinib 15 mg once daily through 152 weeks among patients with psoriatic arthritis (PsA) previously exposed to 1 tumor necrosis factor inhibitor (TNFi). Published in RMD Open, the analysis included 195 patient